Action LTUS LOTUS PHARMACEUTICALS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Lotus Pharmaceuticals, Inc.

Actions

LTUS

US5457152032

Marché Fermé - OTC Markets
Autres places de cotation
 16:06:01 25/04/2024 		Varia. 5j. Varia. 1 janv.
0,005 USD -.--% Graphique intraday de Lotus Pharmaceuticals, Inc. -.--% +16,28%
2023 Amarin et Lotus Pharmaceuticals concluent un accord de distribution exclusive du Vazkepa dans 10 pays asiatiques MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Lotus Achieves Historic Q3 2023 Results with YTD EPS Soaring to a Record NTD 14.19 Marking a 29% Year-on-Year Growth
Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.85 with 285% Growth Year on Year
Lotus Continued Stelar Growth in 2Q 2023 EPS Recorded NTD 4.85 with 285% Growth Year on Year
AMARIN AND LOTUS PHARMACEUTICALS ANNOUNCE EXCLUSIVE PARTNERSHIP AGREEMENT TO COMMERCIALIZE VAZKEPA IN SOUTHEAST ASIA AND SOUTH KOREA
Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries
Lotus Announces MFDS Approval for GRALISE SR, Once-Daily Tablets for Post-Herpetic Neuralgia
Lotus revenues grow by 16% and profit doubles year over year
Lotus acquires Alimta in Taiwan from Lilly
Lotus Pharmaceuticals - Aztiq and Innobic officially become Lotus's majority shareholders
Lotus Reports Solid Performance in First Quarter of 2022
Lotus Pharmaceuticals : Unaudited Financial Statement
Lotus Pharmaceuticals acquires Cialis (Tadalafil) in Taiwan from Lilly
Lotus achieves another record high EPS for FY2021
A powerful investment alliance of Aztiq and Innobic acquires Alvogen's shares in Lotus and Adalvo in a US$475m deal
Thai oil firm PTT expands pharma business with $475 million Alvogen deal
Lotus Pharmaceuticals : Informational Disclosure
Lotus Pharmaceuticals : Unaudited Financial Statements
Lotus Pharmaceuticals : Temasek-backed Vertex expects at least $400 million in new S.E.Asia/India fund
Lotus Pharmaceuticals : PTT invests in Lotus
LOTUS PHARMACEUTICALS, INC. : Other Events (form 8-K)
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action LTUS
  4. Actualités Lotus Pharmaceuticals, Inc.
  5. Autres langues